The journal retracts the article, “Isolation and Characterization of a Novel Lytic Phage, vB_PseuP-SA22, and Its Efficacy against Carbapenem-Resistant Pseudomonas aeruginosa”, cited above.
Following publication, concerns were brought to the attention of the publisher regarding an overlap of the images.
Adhering to our complaints procedure, an investigation was conducted that confirmed the overlap of Figure 8C with a figure in a previously published article [], listing different experimental conditions. While the authors fully cooperated with the Editorial Office during the investigation, they were unable to satisfactorily explain the overlap of the figures or meet the required quality standards for raw images in order to consider a correction as per the journal’s original image requirements policy (https://www.mdpi.com/journal/antibiotics/instructions#oriimages). As a result, the Editorial Board and Editor-in-Chief have lost confidence in the validity of the findings and decided to retract this paper as per MDPI’s retraction policy (https://www.mdpi.com/ethics#_bookmark30).
This retraction was approved by the Editor-in-Chief of the journal Antibiotics.
The authors have agreed to this retraction.
Reference
- Teklemariam, A.D.; Al-Hindi, R.R.; Alharbi, M.G.; Alotibi, I.; Azhari, S.A.; Qadri, I.; Alamri, T.; Esmael, A.; Harakeh, S. RETRACTED: Isolation and Characterization of a Novel Lytic Phage, vB_PseuP-SA22, and Its Efficacy against Carbapenem-Resistant Pseudomonas aeruginosa. Antibiotics 2023, 12, 497. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).